ALK-rearrangements and testing methods in non-small cell lung cancer: a review

The anaplastic lymphoma tyrosine kinase (ALK) gene was first described as a driver mutation in anaplastic non-Hodgkin's lymphoma. Dysregulated ALK expression is now an identified driver mutation in nearly twenty different human malignancies, including 4-9% of non-small cell lung cancers (NSCLC)...

Descripción completa

Detalles Bibliográficos
Autores principales: Shackelford, Rodney E., Vora, Moiz, Mayhall, Kim, Cotelingam, James
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2014
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4063252/
https://www.ncbi.nlm.nih.gov/pubmed/24955213

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4063252/
https://www.ncbi.nlm.nih.gov/pubmed/24955213

Ejemplares similares